BEAM BEAM THERAPEUTICS INC revenue, earnings and financials

For the quarter ended June 30, 2026, BEAM THERAPEUTICS INC reported revenue of $490K (down 94.2% from a year earlier), net income of −$123M and diluted EPS of −$1.18; over the last four quarters revenue was $156M and net income −$86.5M; for the fiscal year ended December 2025 revenue was $140M, up 120.0% on the year before.

BEAM annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $140M, gross profit n/a, operating income −$384M, net income −$80.0M (margin -57.2%), EPS −$0.81
• Fiscal year ended Dec 2024: revenue $63.5M, gross profit n/a, operating income −$416M, net income −$377M (margin -593.1%), EPS −$4.58
• Fiscal year ended Dec 2023: revenue $378M, gross profit n/a, operating income −$176M, net income −$133M (margin -35.1%), EPS −$1.72
• Fiscal year ended Dec 2022: revenue $60.9M, gross profit n/a, operating income −$338M, net income −$289M (margin -474.5%), EPS −$4.13
• Fiscal year ended Dec 2021: revenue $51.8M, gross profit n/a, operating income −$392M, net income −$371M (margin -715.0%), EPS −$5.77

BEAM quarterly revenue and earnings

• Quarter ended Jun 30, 2026: revenue $490K (down 94.2% year over year), net income −$123M, EPS −$1.18
• Quarter ended Mar 31, 2026: revenue $31.7M (up 324.9% year over year), net income −$94.3M, EPS −$0.91
• Quarter ended Dec 31, 2025 (from the annual report): revenue $114M (up 279.5% year over year), net income $243M, EPS $2.52
• Quarter ended Sep 30, 2025: revenue $9.70M (down 32.0% year over year), net income −$113M, EPS −$1.10
• Quarter ended Jun 30, 2025: revenue $8.47M (down 28.1% year over year), net income −$102M, EPS −$1.00
• Quarter ended Mar 31, 2025: revenue $7.47M (up 0.8% year over year), net income −$108M, EPS −$1.23
• Quarter ended Dec 31, 2024 (from the annual report): revenue $30.1M (down 90.5% year over year), net income −$90.4M, EPS −$1.09
• Quarter ended Sep 30, 2024: revenue $14.3M (down 17.0% year over year), net income −$96.7M, EPS −$1.17
• Quarter ended Jun 30, 2024: revenue $11.8M (down 41.5% year over year), net income −$91.1M, EPS −$1.11
• Quarter ended Mar 31, 2024: revenue $7.41M (down 69.4% year over year), net income −$98.7M, EPS −$1.21
• Quarter ended Dec 31, 2023 (from the annual report): revenue $316M (up 1478.0% year over year), net income $143M, EPS $1.91
• Quarter ended Sep 30, 2023: revenue $17.2M (up 8.8% year over year), net income −$96.1M, EPS −$1.22
• Quarter ended Jun 30, 2023: revenue $20.1M (up 20.8% year over year), net income −$82.8M, EPS −$1.08
• Quarter ended Mar 31, 2023: revenue $24.2M (up 187.1% year over year), net income −$96.5M, EPS −$1.33
• Quarter ended Dec 31, 2022 (from the annual report): revenue $20.0M (down 60.8% year over year), net income −$38.3M, EPS −$0.54
• Quarter ended Sep 30, 2022: revenue $15.8M (up 1970.6% year over year), net income −$110M, EPS −$1.56
• Quarter ended Jun 30, 2022: revenue $16.7M (up 277433.3% year over year), net income −$72.0M, EPS −$1.02
• Quarter ended Mar 31, 2022: revenue $8.43M (up 140433.3% year over year), net income −$69.2M, EPS −$1.01
• Quarter ended Dec 31, 2021 (from the annual report): revenue $51.1M, net income −$64.7M, EPS −$0.77
• Quarter ended Sep 30, 2021: revenue $763K, net income −$28.1M, EPS −$0.42

BEAM cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow −$345M, share buybacks n/a
• Fiscal year ended Dec 2024: operating cash flow −$347M, share buybacks n/a
• Fiscal year ended Dec 2023: operating cash flow −$149M, share buybacks n/a
• Fiscal year ended Dec 2022: operating cash flow $22.5M, share buybacks n/a
• Fiscal year ended Dec 2021: operating cash flow −$66.3M, share buybacks n/a

BEAM balance sheet

• Jun 30, 2026: cash $220M, total assets $1.39B, total liabilities $319M, shareholders' equity $1.07B, long-term debt $100M
• Mar 31, 2026: cash $288M, total assets $1.48B, total liabilities $316M, shareholders' equity $1.16B, long-term debt $100M
• Dec 31, 2025: cash $295M, total assets $1.48B, total liabilities $243M, shareholders' equity $1.24B
• Sep 30, 2025: cash $268M, total assets $1.31B, total liabilities $345M, shareholders' equity $966M
• Jun 30, 2025: cash $282M, total assets $1.39B, total liabilities $344M, shareholders' equity $1.05B
• Mar 31, 2025: cash $528M, total assets $1.47B, total liabilities $344M, shareholders' equity $1.13B
• Dec 31, 2024: cash $282M, total assets $1.10B, total liabilities $370M, shareholders' equity $734M
• Sep 30, 2024: cash $230M, total assets $1.17B, total liabilities $380M, shareholders' equity $791M

What is BEAM's revenue?

BEAM THERAPEUTICS INC reported $156M of revenue over its last four quarters, through June 30, 2026.

Is BEAM profitable?

No. BEAM THERAPEUTICS INC lost $86.5M over the last four quarters.

What is BEAM's EPS?

Diluted earnings per share over the last four quarters were −$0.67; −$1.18 in the latest quarter.

BEAM ownership and insider trades · All stocks